Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine-Reference-Cited by-同舟云学术

Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine

Published:2021-03 Issue:3 Volume:110 Page:1054-1066
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Kaur Kawaljit,Xiong Jian,Sawant Nishant,Agarwal Sanjeev,Hickey John M.,Holland David A.,Mukhopadhyay Tarit K.,Brady Joseph R.,Dalvie Neil C.,Tracey Mary Kate,Love Kerry R.,Love J. Christopher,Weis David D.,Joshi Sangeeta B.,Volkin David B.

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries;Drain;Bull World Health Organ,2003

2. Single versus multi-dose vaccine vials: an economic computational model;Lee;Vaccine,2010

3. Antimicrobial preservative use in parenteral products: past and present;Meyer;J Pharm Sci,2007

4. Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?;Offit;Pediatrics,2003

5. An assessment of thimerosal use in childhood vaccines;Ball;Pediatrics,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges;Vaccines;2024-06-03

2. From cell factories to patients: Stability challenges in biopharmaceuticals manufacturing and administration with mitigation strategies;International Journal of Pharmaceutics;2023-10

3. Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies;Journal of Pharmaceutical Sciences;2023-02

4. Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication;Human Vaccines & Immunotherapeutics;2022-12-28

5. Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development;Journal of Pharmaceutical Sciences;2022-11